Profound Historical Income Statement
| PRN Stock | CAD 10.35 0.04 0.38% |
Historical analysis of Profound Medical income statement accounts such as Research Development of 10.2 M, Total Operating Expenses of 21.3 M, Interest Income of 1.5 M or Gross Profit of 5.3 M can show how well Profound Medical Corp performed in making a profits. Evaluating Profound Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Profound Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Profound Medical Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Profound Medical Corp is a good buy for the upcoming year.
Profound |
About Profound Income Statement Analysis
Profound Medical Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Profound Medical shareholders. The income statement also shows Profound investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Profound Medical Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Profound Medical Corp. It is also known as Profound Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Profound Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Profound Medical's Interest Expense is very stable compared to the past year. As of the 23rd of January 2025, Gross Profit is likely to grow to about 5.3 M, while Depreciation And Amortization is likely to drop about 1.4 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 174K | 770K | 693K | 718.0K | Depreciation And Amortization | 2.1M | 1.5M | 1.8M | 1.4M |
Profound Medical income statement Correlations
Click cells to compare fundamentals
Profound Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Profound Medical income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 2.1M | 2.4M | 2.1M | 1.5M | 1.8M | 1.4M | |
| Interest Expense | 543K | 303K | 174K | 770K | 693K | 718.0K | |
| Selling General Administrative | 7.6M | 10.3M | 9.5M | 9.2M | 10.5M | 6.9M | |
| Other Operating Expenses | 26.2M | 37.2M | 36.3M | 35.8M | 41.2M | 23.5M | |
| Operating Income | (18.9M) | (30.3M) | (29.6M) | (28.6M) | (25.8M) | (27.0M) | |
| Ebit | (18.7M) | (30.8M) | (27.6M) | (27.5M) | (24.8M) | (26.0M) | |
| Research Development | 9.9M | 15.3M | 14.7M | 14.4M | 16.5M | 10.2M | |
| Ebitda | (16.6M) | (28.4M) | (25.5M) | (26.0M) | (23.4M) | (24.5M) | |
| Total Operating Expenses | 22.3M | 33.2M | 32.6M | 33.0M | 37.9M | 21.3M | |
| Income Before Tax | (21.6M) | (30.6M) | (28.4M) | (28.7M) | (25.8M) | (27.1M) | |
| Total Other Income Expense Net | (2.7M) | (303K) | 1.2M | (807K) | (726.3K) | (690.0K) | |
| Net Income | (21.6M) | (30.7M) | (28.7M) | (28.6M) | (25.7M) | (27.0M) | |
| Income Tax Expense | 45K | 105K | 287K | (128K) | (147.2K) | (139.8K) | |
| Tax Provision | 45K | 105K | 287K | (128K) | (147.2K) | (139.8K) | |
| Interest Income | 2.6M | 145K | 3.5M | 1.6M | 1.9M | 1.5M | |
| Gross Profit | 3.5M | 3.0M | 3.0M | 4.4M | 5.0M | 5.3M | |
| Net Income From Continuing Ops | (21.6M) | (30.7M) | (28.7M) | (28.6M) | (25.7M) | (27.0M) | |
| Cost Of Revenue | 3.8M | 3.9M | 3.7M | 2.8M | 3.2M | 2.5M | |
| Net Income Applicable To Common Shares | (15.2M) | (21.6M) | (30.7M) | (28.7M) | (25.8M) | (27.1M) | |
| Net Interest Income | 149K | (310K) | 919K | 726K | 834.9K | 876.6K | |
| Total Revenue | 7.3M | 6.9M | 6.7M | 7.2M | 8.3M | 5.2M | |
| Selling And Marketing Expenses | 4.9M | 7.7M | 8.5M | 9.5M | 10.9M | 6.1M | |
| Reconciled Depreciation | 1.5M | 1.9M | 1.6M | 1.1M | 1.3M | 1.5M |
Pair Trading with Profound Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Profound Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Profound Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Profound Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Profound Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Profound Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Profound Medical Corp to buy it.
The correlation of Profound Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Profound Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Profound Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Profound Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .